Tag Archives: Emgality

[ad_1] The FDA has approved Emgality, a subcutaneous injection, once a month, self-administered, for the preventive treatment of migraine in adults, according to a press release issued by the manufacturer. "Despite the …

[ad_1] The US Food and Drug Administration (FDA) has approved galcanezumab-gnlm, an antagonist of calcitonin gene-related peptides (CGRP) (Emgalité, Eli Lilly and Co) for the prevention of migraine in adult patients, reports …